Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-34.00	30.74	46.57
Graham Fair Price	16.28	22.20	19.10
PEG	58.84	0.45	-0.29
Price/Book	-6.15	2.01	2.14
Price/Cash Flow	133.35	-118.13	50.62
Prices/Earnings	-27.52	14.22	19.63
Price/Sales	2.57	11.64	11.35
Price/FCF	133.35	-118.13	50.62
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.06	0.18	0.21
Operating Margin	-2.10	0.13	0.13
ROA	28.54	0.03	0.02
ROE	0.03	0.04	29.50
ROIC	0.02	0.02	-14.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	5.43	-0.24	2187.86
Dividends QOQ	-1.00	7.52	653.56
EBIT QOQ	-0.77	-0.09	88.84
EPS QOQ	-0.69	0.31	-54.37
FCF QOQ	-0.49	-1.41	-189.36
Revenue QOQ	-0.20	-0.07	66.38
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	50.82	36.83	-27.53
Days Sales Outstanding (DSO)	33.58	46.16	37.46
Inventory Turnover	1.77	2.44	37.99
Debt/Capitalization	< 0.005	0.08	1167.17
Quick Ratio	5.09	5.04	-1.01
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	24.37	24.90	2.18
Cash	18.33	19.21	4.78
Capex	0.08	-0.11	34.82
Free Cash Flow	1.03	-0.42	-58.90
Revenue	4.60	4.30	-6.50
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.62	5.42	-3.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-23.26	-15.34	34.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating